Current Paediatrics
Volume 16, Issue 2 , Pages 132-138, April 2006

Melatonin and sleep in children with neurodevelopmental disabilities and sleep disorders

  • E. Wassmer

      Affiliations

    • Neurology Department, Birmingham Children's Hospital, Birmingham, UK
  • ,
  • W.P. Whitehouse

      Affiliations

    • School of Human Development, University of Nottingham, Nottingham, UK
    • Corresponding Author InformationCorresponding author. School of Human Development, University of Nottingham, E Floor, East Block, Queen's Medical Centre, Nottingham NG7 2UH, UK. Tel.: +44(0)1159249924x44476;fax: +44(0)1158230626.

Summary 

Sleep disorders impair the quality of life for children with neurodevelopmental disabilities and their families. Melatonin, a natural regulator of sleep, may be an effective therapy in this area. Numerous studies in children report that melatonin may be beneficial for sleep. Studies differ widely from each other with respect to the dosage and time of administration. The effectiveness of melatonin depends on a number of factors, including dose, the individual sensitivity of the patient and the time of administration. Few acute adverse effects have been reported. Long-term adverse effects have not been systematically studied. Well-designed, randomised, controlled studies with long-term follow-up in children are needed.

Keywords: Melatonin, Sleep, Children, Neurodevelopmental disorders

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0957-5839(06)00002-9

doi:10.1016/j.cupe.2006.01.001

Current Paediatrics
Volume 16, Issue 2 , Pages 132-138, April 2006